Skip to content

USANA Health Sciences USNA Core Nutritional — D&A

Similar metrics at other companies

Phibro Animal Health logo
PAHCMineral Nutrition — D&A
$548K+4.6%
Gentex logo
GNTXOther — D&A
$1.33M+63.4%
Balchem logo
BCPCHuman Nutrition and Health — D&A
$8.65M+18.4%
Balchem logo
BCPCAnimal Nutrition and Health — D&A
$1.86M+5.6%
Campbell Soup logo
CPBMeals & Beverages — D&A
$40M-4.8%
JBT Marel Corporation logo
JBTMPrepared Food and Beverage Solutions — D&A
$31M+14.8%

Other financials

Income statement

See full
Revenue$250.2M+0.3%
Gross profit$190.8M-3.2%
Operating income$13.9M-11.5%
Net income$7.5M-20.1%
EPS (diluted)$0.41-16.3%

Balance sheet

See full
Cash & equivalents$165.7M-9.2%
Total debt$18.0M+10.8%
Total equity$543.6M+2.6%
Total assets$739.0M-1.0%

Cash flow

See full
Operating cash flow$9.8M-37.0%
CapEx$2.6M-5.6%
Free cash flow$7.1M-43.9%

Valuation

See full
Market cap$363.35M-36.1%
P/E18.1×+7.8×
P/S0.4×-0.3×

Profitability

See full
Gross margin77.6%-3.0pp
Operating margin3.8%-2.7pp
Net margin1.9%-4.4pp
FCF margin5.7%-1.1pp

Returns & leverage

See full
Return on equity3.2%-7.6pp
Debt / equity0.0×
Current ratio2.5×+0.5×

Where this comes from

Reported directly by USANA Health Sciences in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: USANA Health Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about USANA Health Sciences's core nutritional — d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is USANA Health Sciences's core nutritional — D&A?
USANA Health Sciences (USNA) reported core nutritional — D&A of $3.6M in Q1 2026.
How has USANA Health Sciences's core nutritional — D&A changed year-over-year?
USANA Health Sciences's core nutritional — D&A decreased by 1.3% year-over-year, from $3.65M to $3.6M.
What does core nutritional — D&A mean?
This represents the total non-cash charges for the depreciation of tangible assets and the amortization of intangible assets specifically allocated to the core nutritional segment. It reflects the consumption of the segment's capital base over time. Investors use this to understand the underlying cash-generating capability of the segment before accounting for capital investment recovery.